The Association for Accessible Medicines, the generic drugmakers' industry group, laid off its top lobbyist and two other executives, and some of the association's K Street firms could be next.
In a letter, the coalition and the trade association said they are “concerned by recent reports that the Administration does not recognize the severe need of the hardest-hit industries that have not received targeted aid.”